Categories: LearnITHealthTechCartCarBioTech
Celularity, headquartered in Florham Park, NJ, is a clinical-stage biotechnology company leading the next evolution in cellular medicine by developing off-the-shelf placental-derived allogeneic cell therapies, including unmodified natural killer (NK) cells, genetically-modified NK cells, T cells engineered with a CAR (CAR T-cells), and mesenchymal-like adherent stromal cells (ASCs) targeting indications across cancer, infectious and degenerative diseases. In addition, Celularity develops and manufactures innovative biomaterials also derived from the postpartum placenta. Celularity believes that by harnessing the placenta’s unique biology and ready availability, it will be able to develop therapeutic solutions that address significant unmet global needs for effective, accessible, and affordable therapies.
Location: United States, New Jersey, Florham Park
Investors 1
Funding Rounds 1
| Date | Series | Amount | Investors |
| 16.02.2018 | - | $250M | - |
Mentions in press and media 16
| Date | Title | Description | Source |
| 12.03.2024 | Celularity CEO to Present Keynote Address at 2024 Society fo... | - | globenewsw... |
| 07.03.2024 | Celularity to Present Data Showing Cancer Tumor Reduction by... | - | globenewsw... |
| 25.01.2024 | Celularity and Genting Leaders Comments on Closing $21 Milli... | - | globenewsw... |
| 27.07.2023 | Celularity Inc. Announces $3 Million Registered Direct Offer... | - | globenewsw... |
| 23.05.2023 | Celularity Announces $45 Million Purchase Order, First Middl... | Builds on Celularity’s December 2022 announcement of Halal Certification of its commercial-stage bio... | einpresswi... |
| 23.05.2023 | Celularity Announces $45 Million Purchase Order, First Middl... | - | globenewsw... |
| 05.04.2023 | Celularity Inc. Announces $6 Million Registered Direct Offer... | - | globenewsw... |
| 11.01.2023 | Celularity and CH Trading Group Announce Territory Distribut... | CH Trading Group will serve as exclusive territories distributor in 100-plus countries with US $225 ... | einpresswi... |
| 16.04.2021 | GX Acquisition Corp. Provides Information Regarding Extensio... | NEW YORK, April 16, 2021 /PRNewswire/ -- On April 14, 2021, GX Acquisition Corp. ("GX") (N... | salamancap... |
| 02.04.2020 | Venture-backed Celularity receives FDA approval for early tr... | Celularity, the venture-backed developer of novel cell therapies for cancer treatments, has received... | techcrunch... |
| 16.02.2018 | Celularity Announces $250M in Funding |
WARREN, NJ, Celularity Announces $250M in Funding to deliver treatments for Cancer, Inflammatory a... | vcnewsdail... |
| 16.02.2018 | Term Sheet — Friday, February 16 | A VALLEY DIVIDED
Good morning, Term Sheet readers.
Paid Content Securing the enterprise without boun... | fortune.co... |
| 15.02.2018 | Celularity Announces $250M in Funding | Celularity has been created through the contribution and acquisition of extensive intellectual prope... | citybizlis... |
| 15.02.2018 | Celularity Announces $250M in Funding | Celularity has been created through the contribution and acquisition of extensive intellectual prope... | archive.ci... |
| 15.02.2018 | Celularity Raises $250M in Funding | Celularity, a Warren, NJ-based newly formed biotechnology company, raised $250M in funding.
Backers ... | finsmes.co... |
| 22.08.2017 |
Sorrento Therapeutics Invests In New Company, Celularity... | San Diego-based biopharmaceuticals developer Sorrento Therapeutics announced on Monday that it has i... | socaltech.... |
Show more
Reviews 0
